Celldex Therapeutics (CLDX) Asset Utilization Ratio (2011 - 2026)
Celldex Therapeutics' (CLDX) Asset Utilization Ratio was 0.00 for Q2 2026, down 97.0% from 0.01 a year earlier and down 84.6% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Dating back to Q3 2011, Celldex Therapeutics' Asset Utilization Ratio record includes 60 quarters.
- By year, Asset Utilization Ratio came in at 0.01 in FY2024 (-33.7%), 0.02 in FY2023 (+184.5%), 0.01 in FY2022 (-56.8%) and 0.01 in FY2021 (-66.9%).
- The Q2 2026 figure ranks as the lowest quarterly Asset Utilization Ratio in data going back to Q3 2011.
- Year over year, Asset Utilization Ratio has now declined in each of the last five quarters, with an average decline of 50.1% over the last eight quarters.
- The high point for year-over-year Asset Utilization Ratio in five years was Q3 2023 (growth of 439.5%); the low point was Q2 2026 (a decline of 97.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 0.00 (Q1 2026), 0.00 (Q4 2025) and 0.00 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 0.47 |
| 10 | Celldex Therapeutics | 2.47 Bn | 2.47 Bn | - | 0.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00 |
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.02 |
API Access
Celldex Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();